Published in Cancer Nanotechnol on March 27, 2013
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med (2001) 44.67
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol (2003) 4.05
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release (2010) 3.06
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc (2003) 2.88
Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev (2008) 2.87
Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A (2005) 2.40
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano (2009) 2.36
In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano (2010) 2.30
Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci (2010) 2.09
Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc (2007) 1.86
Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir (2004) 1.52
From molecules to systems: sol-gel microencapsulation in silica-based materials. Chem Rev (2010) 1.49
Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett (2007) 1.43
Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano (2008) 1.30
The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials (2010) 1.21
Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy. J Mater Chem (2009) 1.11
The development and clinical use of trastuzumab (Herceptin). Endocr Relat Cancer (2002) 1.05
Separation of nanoparticles in a density gradient: FeCo@C and gold nanocrystals. Angew Chem Int Ed Engl (2009) 1.03
Reverse microemulsion-mediated synthesis of silica-coated gold and silver nanoparticles. Langmuir (2008) 0.98
Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging. Opt Express (2008) 0.97
Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett (2011) 0.96
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. Pharmacol Res (2010) 0.91
Organically Modified Silica Nanoparticles with Intraparticle Heavy-Atom Effect on the Encapsulated Photosensitizer for Enhanced Efficacy of Photodynamic Therapy. J Phys Chem C Nanomater Interfaces (2009) 0.88
ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. J Neurosci Methods (2007) 0.87
Colloidal stability of bare and polymer-grafted silica nanoparticles in ionic liquids. Langmuir (2008) 0.84
Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles. Chem Commun (Camb) (2009) 0.82
Photorecovery of nanoparticles from an organic solvent. Langmuir (2008) 0.77
Separating nanoparticles from microemulsions. J Colloid Interface Sci (2010) 0.77
Separation and purification of nanoparticles in a single step. Langmuir (2010) 0.77
Vitamin D3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle. Fertil Steril (2009) 0.90
Mcl-1 is up regulated by prenylated coumarin, umbelliprenin in jurkat cells. Iran J Pharm Res (2014) 0.88
Conjugation of Monoclonal Antibodies to Super Paramagnetic Iron Oxide Nanoparticles for Detection of her2/neu Antigen on Breast Cancer Cell Lines. Avicenna J Med Biotechnol (2009) 0.79
Solid silica nanoparticles: applications in molecular imaging. Contrast Media Mol Imaging (2014) 0.77